REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/01/2025
Back to search
Official data from USPTO
XPAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/02/2025
Trademark type
Word
Nice classes
1, 5
Filing date
05/15/2019
Registration date
12/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2020
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/11/2019
First use in commerce
08/12/2020
Drawing code
4
Owner type
03
Owner location
South San Francisco, CA
Examiner
SCHWARZ,KATHLEEN MICHELLE HUD
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc.
Representatives
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in the manufacture of pharmaceuticals; reagentsenzymesnucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compoundspeptidespeptidomimeticsprotein polymeric intermediates used in the manufacture of pharmaceutical preparations
Class 5
Pharmaceutical preparations for the treatment of cancerous and viral diseases; pharmaceutical preparations for use in the field of oncology; medical diagnostic reagents; reagents for use in testing proteins for medical and diagnostic purposes
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/01/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/27/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/26/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/02/2020
IUAF
USE AMENDMENT FILED
09/29/2020
EISU
TEAS STATEMENT OF USE RECEIVED
09/29/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/24/2020
EX1G
SOU EXTENSION 1 GRANTED
09/23/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/22/2020
EXT1
SOU EXTENSION 1 FILED
09/15/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/15/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/17/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2020
PUBO
PUBLISHED FOR OPPOSITION
01/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
12/19/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/16/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/05/2019
GNRT
NON-FINAL ACTION E-MAILED
08/05/2019
CNRT
NON-FINAL ACTION WRITTEN
08/05/2019
DOCK
ASSIGNED TO EXAMINER
07/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/31/2019
NWAP
NEW APPLICATION ENTERED
05/18/2019
Continuous trademark protection
Get notified about every new filing that threatens XPAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.